Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 09, 2026 02:36 ET | Source: Cytosurge AG

Cytosurge’s CellEDIT Conquers "Impossible" Genome Engineering Challenges

New DTU study uses Cytosurge’s CellEDIT to overcome editing barriers in fragile skin cells, decoding dermokine’s role in wound healing and skin cancer.
April 09, 2025 03:00 ET | Source: Cytosurge AG

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer

Cytosurge appoints Magid Haddouchi, PhD, as CCO and joins key events worldwide to showcase FluidFM tech for single-cell and genome engineering solutions.
May 29, 2024 08:30 ET | Source: Cytosurge AG

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.
May 29, 2024 02:30 ET | Source: Cytosurge AG

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.